Analysis of genetic variants

US9792403B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9792403-B2
Application numberUS-201414274525-A
CountryUS
Kind codeB2
Filing dateMay 9, 2014
Priority dateMay 10, 2013
Publication dateOct 17, 2017
Grant dateOct 17, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and systems for analyzing genetic variants are disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of characterizing a variant in a tumor sample from a subject as being a somatic or germline event, the method comprising: a) sequencing each of a plurality of selected subgenomic intervals, each of a plurality of selected germline SNPs, and a variant, wherein the average sequence coverage prior to normalization is at least about 250×; b) acquiring: i) a sequence coverage input (SCI), which comprises, for each of the plurality of selected subgenomic intervals, a value for normalized sequence coverage at the selected subgenomic intervals, wherein SCI comprises a comparison of the number of reads for a subgenomic interval with the number of reads for a process-matched control; ii) an SNP allele frequency input (SAFI), which comprises, for each of the plurality of selected germline SNPs, a value for a minor allele frequency in the tumor sample; and iii) for said variant being characterized, a variant allele frequency input (VAFI), which comprises the allele frequency for said variant in the tumor sample; c) acquiring values, as a function of SCI and SAFI, for: a genomic segment total copy number (C) for each of a plurality of genomic segments; a genomic segment minor allele copy number (M) for each of the plurality of genomic segments; and sample purity (p), wherein SCI, SAFI, C, M, and p are related to one another by the following: r ij ∼ N ( log 2 ⁢ p * C i + ( 1 - p ) * 2 p * ( ∑ i ⁢ l i ⁢ c i ) / ∑ i ⁢ l i + ( 1 - p ) * 2 , σ ri , and ⁢ ⁢ fik ∼ N ⁡ ( p * Mi + ( 1 - p ) * 1 p * Ci + ( 1 - p ) * 2 , σ ⁢ ⁢ fi ) , when SCI and SAFI are notated as r ij and f ik , respectively; and where r ij is the log ratio (LR) of subgenomic interval j within a genomic segment (S i ), C i is the total copy number (C) of S i , l i is the length of S i , fik is the minor allele frequency of SNP k within S i , M i is the copy number of a minor allele (M) at S i , and σ ri and σ fi are noise parameters; and d) acquiring a value for mutation type, g, for which is indicative of the variant, being somatic, a subclonal somatic variant, germline, or not-distinguishable, wherein g, VAFI, p, C, and M are related to one another by the following: VAFI = pM + g ⁡ ( 1

Assignees

Inventors

Classifications

  • G16B20/00Primary

    ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations · CPC title

  • G06F19/18Primary

    Physics · mapped topic

  • G16B20/20Primary

    Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection · CPC title

  • Ploidy or copy number detection · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9792403B2 cover?
Methods and systems for analyzing genetic variants are disclosed.
Who is the assignee on this patent?
Sun James Xin, Yelensky Roman, Found Medicine Inc
What technology area does this patent fall under?
Primary CPC classification G16B20/00. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).